|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davis JL, Pandalai PK, Ripley RT, Langan
RC and Avital I: Expanding surgical treatment of pancreatic cancer:
the role of regional chemotherapy. Pancreas. 41:678–684. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Z, He N and Zhou Q: Brd4 recruits
P-TEFb to chromosomes at late mitosis to promote G1 gene
expression and cell cycle progression. Mol Cell Biol. 28:967–976.
2008. View Article : Google Scholar :
|
|
5
|
Nicodeme E, Jeffrey KL, Schaefer U, et al:
Suppression of inflammation by a synthetic histone mimic. Nature.
468:1119–1123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Loven J, Hoke HA, Lin CY, et al: Selective
inhibition of tumor oncogenes by disruption of super-enhancers.
Cell. 153:320–334. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chapuy B, McKeown MR, Lin CY, et al:
Discovery and characterization of super-enhancer-associated
dependencies in diffuse large B cell lymphoma. Cancer Cell.
24:777–790. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ott CJ, Kopp N, Bird L, et al: BET
bromodomain inhibition targets both c-Myc and IL7R in high-risk
acute lymphoblastic leukemia. Blood. 120:2843–2852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pastori C, Daniel M, Penas C, et al: BET
bromodomain proteins are required for glioblastoma cell
proliferation. Epigenetics. 9:611–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lockwood WW, Zejnullahu K, Bradner JE and
Varmus H: Sensitivity of human lung adenocarcinoma cell lines to
targeted inhibition of BET epigenetic signaling proteins. Proc Natl
Acad Sci USA. 109:19408–19413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sahai V, Kumar K, Knab LM, et al: BET
bromodomain inhibitors block growth of pancreatic cancer cells in
three-dimensional collagen. Mol Cancer Ther. 13:1907–1917. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berman DM, Karhadkar SS, Maitra A, et al:
Widespread requirement for Hedgehog ligand stimulation in growth of
digestive tract tumours. Nature. 425:846–851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thayer SP, di Magliano MP, Heiser PW, et
al: Hedgehog is an early and late mediator of pancreatic cancer
tumorigenesis. Nature. 425:851–856. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu M, Li L, Liu Z, et al: ABCB2 (TAP1) as
the downstream target of SHH signaling enhances pancreatic ductal
adenocarcinoma drug resistance. Cancer Lett. 333:152–158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Segura MF, Fontanals-Cirera B,
Gaziel-Sovran A, et al: BRD4 sustains melanoma proliferation and
represents a new target for epigenetic therapy. Cancer Res.
73:6264–6276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Gholamin S, Schubert S, et al:
Epigenetic targeting of Hedgehog pathway transcriptional output
through BET bromodomain inhibition. Nat Med. 20:732–740. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Onishi H, Kai M, Odate S, et al: Hypoxia
activates the hedgehog signaling pathway in a ligand-independent
manner by upregulation of Smo transcription in pancreatic cancer.
Cancer Sci. 102:1144–1150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nolan-Stevaux O, Lau J, Truitt ML, et al:
GLI1 is regulated through Smoothened-independent mechanisms in
neoplastic pancreatic ducts and mediates PDAC cell survival and
transformation. Genes Dev. 23:24–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel AJ, Liao CP, Chen Z, Liu C, Wang Y
and Le LQ: BET bromodomain inhibition triggers apoptosis of
NF1-associated malignant peripheral nerve sheath tumors through Bim
induction. Cell Rep. 6:81–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamoureux F, Baud’huin M, Rodriguez
Calleja L, et al: Selective inhibition of BET bromodomain
epigenetic signalling interferes with the bone-associated tumour
vicious cycle. Nat Commun. 5:35112014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez RM, Huidobro C, Urdinguio RG, et
al: Aberrant epigenetic regulation of bromodomain BRD4 in human
colon cancer. J Mol Med. 90:587–595. 2012. View Article : Google Scholar
|
|
22
|
Crawford NP, Alsarraj J, Lukes L, et al:
Bromodomain 4 activation predicts breast cancer survival. Proc Natl
Acad Sci USA. 105:6380–6385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mertz JA, Conery AR, Bryant BM, et al:
Targeting MYC dependence in cancer by inhibiting BET bromodomains.
Proc Natl Acad Sci USA. 108:16669–16674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Geissler K and Zach O: Pathways involved
in Drosophila and human cancer development: the Notch, Hedgehog,
Wingless, Runt, and Trithorax pathway. Ann Hematol. 91:645–669.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Teglund S and Toftgård R: Hedgehog beyond
medulloblastoma and basal cell carcinoma. Biochim Biophys Acta.
1805:181–208. 2010.PubMed/NCBI
|
